Antibody fragment (linker)

[{"image":"https://icons.cdn.biorender.com/w75xh75/5c264ddfc405e91300bc0ba9/5c264daac405e91300bc0b9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264ddfc405e91300bc0ba9/5c264daac405e91300bc0b9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264ddfc405e91300bc0ba8/5c264daac405e91300bc0b9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264ddfc405e91300bc0ba8/5c264daac405e91300bc0b9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264ddfc405e91300bc0ba7/5c264daac405e91300bc0b9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264ddfc405e91300bc0ba7/5c264daac405e91300bc0b9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264ddfc405e91300bc0ba6/5c264daac405e91300bc0b9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264ddfc405e91300bc0ba6/5c264daac405e91300bc0b9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264ddfc405e91300bc0ba5/5c264daac405e91300bc0b9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264ddfc405e91300bc0ba5/5c264daac405e91300bc0b9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264ddfc405e91300bc0ba4/5c264daac405e91300bc0b9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264ddfc405e91300bc0ba4/5c264daac405e91300bc0b9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264ddfc405e91300bc0ba3/5c264daac405e91300bc0b9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264ddfc405e91300bc0ba3/5c264daac405e91300bc0b9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264ddfc405e91300bc0ba2/5c264daac405e91300bc0b9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264ddfc405e91300bc0ba2/5c264daac405e91300bc0b9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264ddfc405e91300bc0ba1/5c264daac405e91300bc0b9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264ddfc405e91300bc0ba1/5c264daac405e91300bc0b9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264ddfc405e91300bc0ba0/5c264daac405e91300bc0b9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264ddfc405e91300bc0ba0/5c264daac405e91300bc0b9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264ddfc405e91300bc0b9f/5c264daac405e91300bc0b9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264ddfc405e91300bc0b9f/5c264daac405e91300bc0b9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264ddfc405e91300bc0b9e/5c264daac405e91300bc0b9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264ddfc405e91300bc0b9e/5c264daac405e91300bc0b9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264ddfc405e91300bc0b9d/5c264daac405e91300bc0b9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264ddfc405e91300bc0b9d/5c264daac405e91300bc0b9b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264ddfc405e91300bc0b9c/5c264daac405e91300bc0b9b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264ddfc405e91300bc0b9c/5c264daac405e91300bc0b9b.png"}]